Abeona Therapeutics Inc. filed a Form 8-K with the SEC on August 13, 2026, announcing the release of its financial results for the quarter ended June 30, 2026.

Key Highlights

  • Filing date: August 13, 2026, the same date as the earliest reported event.
  • Reporting period: Quarter ended June 30, 2026.
  • Press release furnished: A press release dated August 13, 2026, was attached as Exhibit 99.1 and incorporated by reference under Item 2.02.
  • Signed by: Joseph Vazzano, Chief Financial Officer of Abeona Therapeutics Inc.
  • Exchange listing: Common Stock, $0.01 par value, trading as NASDAQ:ABEO on The Nasdaq Capital Market.

Abeona Therapeutics Furnishes Q2 2026 Earnings Press Release

Abeona Therapeutics Inc. (NASDAQ:ABEO), a Delaware-incorporated company headquartered at 6555 Carnegie Ave, 4th Floor, Cleveland, OH 44103, filed a current report on August 13, 2026, under Item 2.02 (Results of Operations and Financial Condition) of the Securities Exchange Act of 1934. According to the filing, the company issued a press release on that date covering its financial results for the quarter ended June 30, 2026.

The filing states that the press release, furnished as Exhibit 99.1, is incorporated into Item 2.02 by reference. The filing also notes that the information in Item 2.02 and Exhibit 99.1 "shall not be deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934, as amended," and is not subject to the liabilities of that section, nor automatically incorporated by reference into other filings under the Securities Act of 1933 unless expressly specified.

The report was signed by Joseph Vazzano in his capacity as Chief Financial Officer. The company's Commission File Number is 001-15771, and its I.R.S. Employer Identification Number is 83-0221517, according to the filing's cover page.

What Was Disclosed

Abeona Therapeutics filed an 8-K on August 13, 2026, furnishing a press release as Exhibit 99.1 covering its financial results for the quarter ended June 30, 2026. No specific financial figures were included in the 8-K body itself.